Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Neutral

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Organogenesis Holdings Inc. Class A Common Stock (ORGO)

Pharmaceutical Preparations

https://www.organogenesis.com

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.

85 DAN ROAD
CANTON, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/29/2016

Market Cap

334,088,997

Shares Outstanding

132,039,999

Weighted SO

131,312,616

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

SHPH --.--%

MNK --.--%

LSDI --.--%

ALIM --.--%

LFCR --.--%

RDHL --.--%

TARO --.--%

COLL --.--%

ADMP --.--%

Beta

1.6500

Last Div

0.0000

Range

1.96-4.705

Chg

-0.0050

Avg Vol

975383

Mkt Cap

334088997

Exch

NASDAQ

Country

US

Phone

781 575 0775

DCF Diff

5.2833

DCF

-2.6233

Div Yield

0.0000

P/S

0.7451

EV Multiple

10.8696

P/FV

1.2679

Div Yield %

0.0000

P/E

-43.9353

PEG

-2.9107

Payout

0.0000

Current Ratio

2.7319

Quick Ratio

2.4183

Cash Ratio

1.0554

DSO

86.2413

DIO

79.3740

Op Cycle

165.6153

DPO

86.7761

CCC

78.8392

Gross Margin

0.7243

Op Margin

0.0307

Pretax Margin

-0.0291

Net Margin

-0.0170

Eff Tax Rate

0.4170

ROA

-0.0172

ROE

-0.0277

ROCE

0.0385

NI/EBT

0.5830

EBT/EBIT

-0.9481

EBIT/Rev

0.0307

Debt Ratio

0.1716

D/E

0.2886

LT Debt/Cap

0.1797

Total Debt/Cap

0.2240

Int Coverage

-286.5833

CF/Debt

0.2883

Equity Multi

1.6818

Rec Turnover

4.2323

Pay Turnover

4.2062

Inv Turnover

4.5985

FA Turnover

3.5441

Asset Turnover

1.0118

OCF/Share

0.1654

FCF/Share

0.0643

Cash/Share

0.6825

OCF/Sales

0.0489

FCF/OCF

0.3886

CF Coverage

0.2883

ST Coverage

1.1967

CapEx Coverage

1.6355

Div&CapEx Cov

1.6355

P/BV

1.2679

P/B

1.2679

P/S

0.7451

P/E

-43.9353

P/FCF

39.2169

P/OCF

15.2383

P/CF

15.2383

PEG

-2.9107

P/S

0.7451

EV Multiple

10.8696

P/FV

1.2679

DPS

0.0000

Latest Headlines (EST)

The Motley Fool Feb 28, 05:45 Organogenesis (ORGO) Q4 2024 Earnings Call Transcript Benzinga Dec 27, 09:06 Meta To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday

Revenue Product Segmentation